Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Eastroc Beverage (09980) will distribute a final dividend of $25 for every 10 shares.

A-share subscription | The "Ning Wang" cooperative partner, Shangshui Intelligence (301513.SZ), has started subscription for the domestic market share of 60% in the circulation pulping system.

On April 7, Jiangsu Hengrui Pharmaceuticals (01276) spent 3.6215 million yuan to repurchase 64,800 A shares.
Eastroc Beverage (09980) will distribute a final dividend of $25 for every 10 shares.

A-share subscription | The "Ning Wang" cooperative partner, Shangshui Intelligence (301513.SZ), has started subscription for the domestic market share of 60% in the circulation pulping system.

On April 7, Jiangsu Hengrui Pharmaceuticals (01276) spent 3.6215 million yuan to repurchase 64,800 A shares.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


